Recombinant SARS-CoV-2, S1-mFc ProteinRecombinant SARS-CoV-2, S1-mFc Protein
Move your mouse over image or click to enlarge

Recombinant SARS-CoV-2, S1-mFc Protein

This recombinant SARS-CoV-2 S1 protein is with the mFc tag. The SARS-CoV-2 Spike (S) Protein consists of the S1 and S2 domains. The S1 subunit contains the N-terminal domain (NTD) and receptor-binding domain (RBD). The S1 subunit recognizes and binds to angiotensin-converting enzyme 2 (ACE2) receptors on target cells through the RBD portion, and subsequent conformational changes in S2 allow for fusion between the viral envelope and host cell membrane. SARS-CoV-2 is closely related to the SARS virus, which was first identified in 2002-20031. Both SARS-CoV and SARS-CoV-2 utilize the ACE2 cell receptor to gain entry into cells, with SARS-CoV-2 binding with higher affinity2. Vaccine and therapeutic development are targeting portions of the spike protein, including the S1 portion3.
Cat# Size Price Qty Buy
S855-1.0mg 1.0 mg
£2,437.50
S855-500ug 500 ug
£1,828.13
S855-100ug 100 ug
£515.63

Additional Information

Property Value or Rating
Manufacturer Cat# S855
Concentration 0.5 mg/ml
Formulation This recombinant protein is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium, calcium or preservatives added.
Manufacturer Leinco Technologies Inc
Applications ELISA
Storage This recombinant protein may be stored as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Protein SARS-CoV-2

Related Documents